Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""Capri, G."" wg kryterium: Autor


Wyświetlanie 1-8 z 8
Tytuł :
An open-label expanded access study of lapatinib and capecitabine in patients with HER2-overexpressing locally advanced or metastatic breast cancer.
Autorzy :
Capri G; Department of Medical Oncology, Fondazione IRCCS Istituto Tumori, Milano, Italy. Electronic address: giuseppe.capri@istitutotumori.mi.it.
Chang J; Medical Oncology Program, RS McLaughlin Durham Regional Cancer Centre, Oshawa, Ontario, Canada.
Chen SC; Department of General Surgery, Chang Gung Memorial Hospital, Taipei, Taiwan.
Conte P; Department of Oncology and Hematology, Universita degli Studi di Modena e Reggio Emilia, Modena, Italy.
Cwiertka K; Department of Oncology, Hospital Olomouc, Olomouc, Czech Republic.
Jerusalem G; Department of Medical Oncology, CHU Liège Hospital du Sart-Tilman, Liège, Belgium.
Jiang Z; Breast Cancer Department, The Hospital Associated With Military Medical Science, Beijing, China.
Johnston S; Department of Medical Oncology, Royal Marsden NHS Foundation Trust & Institute of Cancer Research, London, UK.
Kaufman B; Breast Cancer Unit, Sheba Medical Center, Ramat Gan, Israel.
Link J; Breast Link Medical Group, Inc., Long Beach, CA, USA.
Ro J; Breast and Endocrine Cancer Branch, National Cancer Center, Kyunggi-do, South Korea.
Schütte J; Department of Hematology and Oncology, Marien Hospital Düsseldorf, Düsseldorf, Germany.
Oliva C; Oncology Medicine Development Center, GlaxoSmithKline, Uxbridge, Middlesex, UK.
Parikh R; Oncology Medicine Development Center, GlaxoSmithKline, Uxbridge, Middlesex, UK.
Preston A; Oncology Medicine Development Center, GlaxoSmithKline, Collegeville, PA, USA.
Rosenlund J; Oncology Medicine Development Center, GlaxoSmithKline, Collegeville, PA, USA.
Selzer M; Oncology, Global Clinical Safety and Pharmacovigilance, GlaxoSmithKline, Collegeville, PA, USA.
Zembryki D; Oncology Medicine Development Center, GlaxoSmithKline, Collegeville, PA, USA.
De Placido S; Department of Molecular and Clinical Oncology, Universita degli Studi di Napoli Federico II, Napoli, Italy.
Pokaż więcej
Źródło :
Annals of oncology : official journal of the European Society for Medical Oncology [Ann Oncol] 2010 Mar; Vol. 21 (3), pp. 474-480. Date of Electronic Publication: 2009 Oct 08.
Typ publikacji :
Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Antineoplastic Combined Chemotherapy Protocols/*therapeutic use
Brain Neoplasms/*drug therapy
Brain Neoplasms/*metabolism
Breast Neoplasms/*drug therapy
Breast Neoplasms/*metabolism
Receptor, ErbB-2/*metabolism
Adult ; Aged ; Aged, 80 and over ; Brain Neoplasms/secondary ; Breast Neoplasms/pathology ; Capecitabine ; Deoxycytidine/administration & dosage ; Deoxycytidine/analogs & derivatives ; Drug Administration Schedule ; Female ; Fluorouracil/administration & dosage ; Fluorouracil/analogs & derivatives ; Follow-Up Studies ; Humans ; Lapatinib ; Lymphatic Metastasis ; Middle Aged ; Quinazolines/administration & dosage ; Safety ; Survival Rate ; Treatment Outcome ; Young Adult
Czasopismo naukowe
Tytuł :
Clinical and pharmacological phase I evaluation of Exherin (ADH-1), a selective anti-N-cadherin peptide in patients with N-cadherin-expressing solid tumours.
Autorzy :
Perotti A; Fondazione IRCCS Istituto Nazionale Tumori, Milano, Italy.
Sessa C
Mancuso A
Noberasco C
Cresta S
Locatelli A
Carcangiu ML
Passera K
Braghetti A
Scaramuzza D
Zanaboni F
Fasolo A
Capri G
Miani M
Peters WP
Gianni L
Pokaż więcej
Źródło :
Annals of oncology : official journal of the European Society for Medical Oncology [Ann Oncol] 2009 Apr; Vol. 20 (4), pp. 741-5. Date of Electronic Publication: 2009 Feb 03.
Typ publikacji :
Clinical Trial, Phase I; Journal Article
MeSH Terms :
Antineoplastic Agents/*therapeutic use
Cadherins/*antagonists & inhibitors
Neoplasms/*drug therapy
Peptides, Cyclic/*therapeutic use
Antineoplastic Agents/adverse effects ; Antineoplastic Agents/pharmacokinetics ; Cadherins/metabolism ; Humans ; Magnetic Resonance Imaging ; Maximum Tolerated Dose ; Neoplasms/metabolism ; Neoplasms/pathology ; Peptides, Cyclic/adverse effects ; Peptides, Cyclic/pharmacokinetics
Czasopismo naukowe
Tytuł :
Concerted escalation of dose and dosing duration in a phase I study of the oral camptothecin gimatecan (ST1481) in patients with advanced solid tumors.
Autorzy :
Sessa C; Istituto Oncologico della Svizzera Italiana, Bellinzona, Switzerland.
Cresta S
Cerny T
Baselga J
Rota Caremoli E
Malossi A
Hess D
Trigo J
Zucchetti M
D'Incalci M
Zaniboni A
Capri G
Gatti B
Carminati P
Zanna C
Marsoni S
Gianni L
Pokaż więcej
Źródło :
Annals of oncology : official journal of the European Society for Medical Oncology [Ann Oncol] 2007 Mar; Vol. 18 (3), pp. 561-8. Date of Electronic Publication: 2006 Dec 05.
Typ publikacji :
Clinical Trial, Phase I; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
MeSH Terms :
Antineoplastic Agents, Phytogenic/*administration & dosage
Camptothecin/*analogs & derivatives
Neoplasms/*drug therapy
Administration, Oral ; Adult ; Aged ; Aged, 80 and over ; Antineoplastic Agents, Phytogenic/adverse effects ; Antineoplastic Agents, Phytogenic/pharmacokinetics ; Camptothecin/administration & dosage ; Camptothecin/adverse effects ; Camptothecin/pharmacokinetics ; Dose-Response Relationship, Drug ; Drug Administration Schedule ; Europe ; Female ; Half-Life ; Humans ; Male ; Middle Aged ; Neoplasms/pathology ; Treatment Outcome
Czasopismo naukowe
Tytuł :
A randomized phase II study of combination, alternating and sequential regimens of doxorubicin and docetaxel as first-line chemotherapy for women with metastatic breast cancer.
Autorzy :
Cresta S; Department of Oncology, Istituto Nazionale Tumori, Milan, Italy.
Grasselli G
Mansutti M
Martoni A
Lelli G
Capri G
Buzzi F
Cuna GR
Jirillo A
Terzoli E
Frevola L
Tarenzi E
Sguotti C
Azli N
Murawsky M
Gianni L
Pokaż więcej
Źródło :
Annals of oncology : official journal of the European Society for Medical Oncology [Ann Oncol] 2004 Mar; Vol. 15 (3), pp. 433-9.
Typ publikacji :
Clinical Trial; Clinical Trial, Phase II; Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
MeSH Terms :
Antineoplastic Combined Chemotherapy Protocols/*therapeutic use
Breast Neoplasms/*drug therapy
Adolescent ; Adult ; Aged ; Antineoplastic Combined Chemotherapy Protocols/adverse effects ; Breast Neoplasms/mortality ; Breast Neoplasms/secondary ; Disease Progression ; Docetaxel ; Doxorubicin/administration & dosage ; Female ; Humans ; Middle Aged ; Survival Rate ; Taxoids/administration & dosage ; Time Factors
Czasopismo naukowe
Tytuł :
Clinical and pharmacological phase I study with accelerated titration design of a daily times five schedule of BBR3464, a novel cationic triplatinum complex.
Autorzy :
Sessa C; Istituto Oncologico della Svizzera Italiana, Bellinzona, Switzerland.
Capri G
Gianni L
Peccatori F
Grasselli G
Bauer J
Zucchetti M
Viganò L
Gatti A
Minoia C
Liati P
Van den Bosch S
Bernareggi A
Camboni G
Marsoni S
Pokaż więcej
Źródło :
Annals of oncology : official journal of the European Society for Medical Oncology [Ann Oncol] 2000 Aug; Vol. 11 (8), pp. 977-83.
Typ publikacji :
Clinical Trial; Clinical Trial, Phase I; Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Antineoplastic Agents/*administration & dosage
Neoplasms/*drug therapy
Organoplatinum Compounds/*administration & dosage
Adolescent ; Adult ; Aged ; Antineoplastic Agents/adverse effects ; Antineoplastic Agents/pharmacokinetics ; Dose-Response Relationship, Drug ; Drug Administration Schedule ; Female ; Humans ; Male ; Middle Aged ; Neoplasms/metabolism ; Organoplatinum Compounds/adverse effects ; Organoplatinum Compounds/pharmacokinetics
Czasopismo naukowe
Tytuł :
Biweekly paclitaxel and cisplatin in patients with advanced head and neck carcinoma. A phase II trial.
Autorzy :
Licitra L; Division of Medical Oncology, Istituto Nazionale Tumori, Milan, Italy. />Capri G
Fulfaro F
Grandi C
Tarenzi E
Cavina R
Gianni L
Pokaż więcej
Źródło :
Annals of oncology : official journal of the European Society for Medical Oncology [Ann Oncol] 1997 Nov; Vol. 8 (11), pp. 1157-8.
Typ publikacji :
Clinical Trial; Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Antineoplastic Combined Chemotherapy Protocols/*therapeutic use
Head and Neck Neoplasms/*drug therapy
Adult ; Aged ; Carcinoma/drug therapy ; Carcinoma, Squamous Cell/drug therapy ; Cisplatin/administration & dosage ; Drug Administration Schedule ; Female ; Humans ; Infusions, Intravenous ; Male ; Middle Aged ; Nasopharyngeal Neoplasms/drug therapy ; Paclitaxel/administration & dosage ; Palliative Care ; Treatment Outcome
Czasopismo naukowe
Tytuł :
Activity and toxicity of 4'-iodo-4'-deoxydoxorubicin in patients with advanced breast cancer.
Autorzy :
Gianni L; Division of Medical Oncology, Istituto Nazionale per lo Studio e la Cura dei Tumori, Milan, Italy.
Capri G
Greco M
Villani F
Brambilla C
Luini A
Crippa F
Bonadonna G
Pokaż więcej
Źródło :
Annals of oncology : official journal of the European Society for Medical Oncology [Ann Oncol] 1991 Nov-Dec; Vol. 2 (10), pp. 719-25.
Typ publikacji :
Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Breast Neoplasms/*drug therapy
Doxorubicin/*analogs & derivatives
Adult ; Aged ; Doxorubicin/adverse effects ; Doxorubicin/therapeutic use ; Drug Evaluation ; Female ; Humans ; Middle Aged
Czasopismo naukowe
    Wyświetlanie 1-8 z 8

    Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies